TY - JOUR
TI - High-grade B-cell lymphoma of the peritoneum as a result of transformation of a CD5-negative monoclonal B lymphocytosis population in a patient with myelodysplastic syndrome treated with 5-azacytidine
AU - Dimou, M.
AU - Roumelioti, M.
AU - Dimitrakopoulou, A.
AU - Bitsani, C.
AU - Kotsanti, S.
AU - Petsa, P.
AU - Papaioannou, P.
AU - Kyrtsonis, M.-C.
AU - Panayiotidis, P.
JO - Clinical Lymphoma Myeloma and Leukemia
PY - 2018
VL - 59
TODO - 5
SP - 1264-1267
PB - Taylor and Francis Ltd.
SN - null
TODO - 10.1080/10428194.2017.1375108
TODO - azacitidine;  CD19 antigen;  CD20 antigen;  CD23 antigen;  CD5 antigen;  CD79b antigen;  cyclophosphamide plus doxorubicin plus prednisolone plus rituximab plus vincristine;  antineoplastic antimetabolite;  azacitidine;  CD5 antigen, aged;  anemia;  ascites fluid;  B cell lymphoma;  bone marrow biopsy;  cancer incidence;  cancer patient;  cancer staging;  case report;  chronic lymphatic leukemia;  clinical article;  comparative study;  computer assisted tomography;  cytogenetics;  DNA sequence;  erythrocyte transfusion;  flow cytometry;  human;  immunophenotyping;  Letter;  male;  medical history;  monoclonal b cell lymphocytosis;  myelodysplastic syndrome;  peritoneum tumor;  priority journal;  refractory anemia with excess blasts;  refractory cytopenia with multilineage dysplasia;  thrombocytopenia;  treatment duration;  B cell lymphoma;  chemically induced;  complication;  drug effect;  lymphocytosis;  metabolism;  myelodysplastic syndrome;  pathology;  peritoneum;  prognosis, Aged;  Antimetabolites, Antineoplastic;  Azacitidine;  CD5 Antigens;  Humans;  Lymphocytosis;  Lymphoma, B-Cell;  Male;  Myelodysplastic Syndromes;  Peritoneum;  Prognosis
TODO - null
ER -